![Tadashi Nakamura](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tadashi Nakamura
No más puestos en curso
Perfil
Tadashi Nakamura worked as a Director & Manager-Production Development at UMN Pharma, Inc. and as a Director at UNIGEN Inc. He obtained a doctorate degree from Gunma University.
Antiguos cargos conocidos de Tadashi Nakamura.
Empresas | Cargo | Fin |
---|---|---|
UNIGEN Inc.
![]() UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | Director/Miembro de la Junta | - |
UMN PHARMA INC. | Director/Miembro de la Junta | - |
Formación de Tadashi Nakamura.
Gunma University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
UMN Pharma, Inc.
![]() UMN Pharma, Inc. Pharmaceuticals: MajorHealth Technology UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It operates through a following business division: Next-generation biopharmaceutical in-house development business and Biopharmaceutical contract manufacturing business. The Next-generation biopharmaceutical in-house development business engages in the research and development of next-generation logical vaccine by integrating next-generation biopharmaceutical drug substance manufacturing technology, adjuvant technology and drug delivery technology. The Biopharmaceutical contract manufacturing business offers study samples, investigational drugs, products, and various evaluation test results. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan. | Health Technology |
UNIGEN Inc.
![]() UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Tadashi Nakamura